Target species
Chickens (breeder and layer pullets).
Indications for use
Booster immunisation of breeder and layer pullets after vaccination with live vaccines against:
- Newcastle disease virus in order to reduce egg drop linked to Newcastle disease infection,
- Infectious bronchitis virus in order to reduce egg drop linked to Infectious Bronchitis infection caused by the Mass41 strain,
- Avian pneumovirus in order to reduce respiratory signs linked to avian pneumovirus infection (swollen head syndrome).
Active immunisation of breeder and layer pullets in order to reduce egg drop linked to infection with egg drop syndrome virus (EDS76) without priming.
Newcastle disease, infectious bronchitis and egg drop syndrome components:
- Onset of immunity: 4 weeks after vaccination
- Duration of immunity: one laying period
Turkey rhinotracheitis component:
- Onset of immunity: 14 weeks after vaccination
- Duration of immunity: one laying period
Contraindications
None
Special warnings for each target species
Vaccinate healthy animals only.
Special precautions for use
Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the product to animals
To the user: This veterinary medicinal product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you.
If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician: This veterinary medicinal product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling which may, for example, result in ischaemic necrosis and even loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Special precautions for the protection of the environment
Not applicable
Adverse reactions
Chickens:
Very common (> 1 animal / 10 animals treated): | Abnormal histology. 1 |
1 At the injection site. Lesions linked to the oily adjuvant were histologically observed in 87% of cases three weeks after injection, e.g. small quantities of oily residues and occasional aseptic micro-abscesses. No palpable reactions were observed.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
Do not use in birds in lay and within 4 weeks before the start of the laying period.
Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Amount(s) to be administered and administration route
Administer one dose (0.3 ml) by intramuscular route from the age of 18 weeks and at least 4 weeks after the priming with live vaccines against Newcastle disease (strain Hitchner B1 or VG/GA-AVINEW), infectious bronchitis (strain Mass H120), and avian pneumovirus (strain PL21).
Shake well before use.
Apply usual aseptic procedures.
Do not use syringes with natural rubber or butyl elastomer pistons.
Equipment including needles and syringes must be sterile before use.
Overdose (symptoms, emergency procedures, antidotes), if necessary
In addition to the adverse events mentioned in paragraph “Adverse events”, transitory apathy and slight oedema at injection site may occur after the administration of a double dose of vaccine.
Withdrawal period(s)
Zero days.